Investor Relations
Our Vision

We look for answers in unexpected places & vigorously test our hypotheses to deliver ground-breaking advances to patients.

Careful Planning for Success

Inmedix specializes in understanding key diagnostics

The current Inmedix project is to bring cloud-based heart rate variability (HRV) through appropriate regulated pathways (FDA) as a safe and effective precision diagnostic for those clinicians already familiar with HRV.  Next, Inmedix intends to seek a series clinical intended uses based on data that the FDA deems appropriate for validated applications to improve healthcare outcomes.

Inmedix is a privately held corporation (DE) that seeks like-minded individuals and institutions to support our mission of understanding why patients respond differently to the same treatment.  Please contact our Corporate Development Team for more information about Inmedix.


This website contains certain forward-looking statements, including without limitation statements regarding Inmedix’s plans for preclinical studies and product capabilities. You are cautioned that such forward-looking statements are not guarantees of future performance and involve risks and uncertainties inherent in Inmedix’s business which could significantly affect expected results, including without limitation, progress of development, clinical testing and regulatory approval, developments in raw material and personnel costs, and legislative, fiscal, and other regulatory measures.  All forward-looking statements are qualified in their entirety by this cautionary statement, and Inmedix undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release. This is not an offer to sell or an offer to purchase securities.